Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
PLoS One ; 16(2): e0244664, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33635870

RESUMEN

BACKGROUND: Hydrocele is a chronic condition in males in which there is an excessive collection of straw-colored fluid, which leads to enlargement of the scrotum. It is a common manifestation of lymphatic filariasis (LF) affecting nearly 25 million men worldwide. Surgery is the recommended treatment for hydrocele and is available free of cost in all government hospitals in Nepal. This research explored patient, provider, and community factors related to accessing hydrocele surgery services by the patients. METHODS: This study employed a qualitative method. The research was conducted in two LF endemic districts, namely Kanchanpur and Dhading, which are reported to have the highest number of hydrocele cases during morbidity mapping conducted in 2016. In addition to five key informant interviews with the LF focal persons (one national and 4 district-level), nine in-depth interviews were conducted with hydrocele patients (5 of whom had undergone surgery and 4 who had not undergone surgery) and with 3 family members, and two focus group discussions with the female community health volunteers. RESULTS: Most of the respondents did not have knowledge of hydrocele as one of the clinical manifestations of LF nor that it is transmitted through a mosquito bite. Although perceived as treatable with surgery, most of the patients interviewed believed in as well as practiced home remedies. Meanwhile, fear of surgery, embarrassment, lack of money, along with no knowledge of the free hydrocele surgery acted as barriers for accessing the surgery. On the other hand, financial support, flexible guidelines enabling the hospital to conduct surgery, decentralization and scaling up of morbidity mapping along with free hydrocele surgery camps in any remaining endemic districts were identified as enablers for accessing surgery. CONCLUSION: Hydrocele surgery coverage could be improved if the program further addresses community awareness. There is a need for more focus on information dissemination about hydrocele and hydrocele surgery.


Asunto(s)
Filariasis Linfática/epidemiología , Accesibilidad a los Servicios de Salud/tendencias , Hidrocele Testicular/cirugía , Adulto , Anciano , Filariasis Linfática/complicaciones , Filariasis Linfática/cirugía , Femenino , Grupos Focales , Conocimientos, Actitudes y Práctica en Salud/etnología , Humanos , Masculino , Persona de Mediana Edad , Nepal/epidemiología , Salud Pública , Participación de los Interesados , Encuestas y Cuestionarios , Hidrocele Testicular/epidemiología
2.
J Pediatr Surg ; 46(12): 2401-5, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22152892

RESUMEN

BACKGROUND: There is little consensus over the optimal timing of ligation of a patent processus vaginalis (PPV) in boys with hydrocele. We hypothesized that a proportion of procedures may be unnecessary because they are performed at an age before which the PPV may be expected to close spontaneously. Such excess may expose the child to unnecessary surgery and have significant cost implications. METHODS: A systematic literature review relating to timing of PPV ligation and a population-based study to define number of PPV ligations performed annually in England and age at surgery were conducted. RESULTS: Most hydroceles resolve before 2 years of age, but their natural history beyond this age is poorly documented. Current guidelines recommend PPV ligation at 2 years of age. An average of 2878 operations for hydrocele is performed per year in children in England. Commonest age at repair is 2 years. There are no randomized controlled trials comparing PPV ligation with an observational nonoperative approach. CONCLUSIONS: The natural history of hydrocele is poorly documented beyond the age of 2 years. There is no good evidence to support current practice. Delaying surgery may reduce the number of procedures necessary without increasing morbidity. A prospective study to investigate this is warranted.


Asunto(s)
Hidrocele Testicular/cirugía , Procedimientos Innecesarios , Factores de Edad , Preescolar , Ahorro de Costo , Inglaterra/epidemiología , Humanos , Lactante , Ligadura/economía , Ligadura/estadística & datos numéricos , Ligadura/tendencias , Masculino , Programas Nacionales de Salud/economía , Guías de Práctica Clínica como Asunto , Remisión Espontánea , Hidrocele Testicular/epidemiología , Procedimientos Innecesarios/economía , Procedimientos Innecesarios/estadística & datos numéricos
3.
Am J Trop Med Hyg ; 80(6): 956-63, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19478258

RESUMEN

The treatment for hydrocele is expensive, invasive surgery-hydrocelectomy. A drug that could prevent or improve this condition could replace or supplement hydrocelectomy. In Ghana, 42 hydrocele patients participated in a double-blind, placebo-controlled trial of a six-week regimen of doxycycline, 200 mg/day. Four months after doxycycline treatment, patients received 150 mug/kg of ivermectin and 400 mg of albendazole, which is used for mass chemotherapy in this area. Patients were monitored for levels of Wolbachia sp., microfilaremia, antigenemia, plasma levels of vascular endothelial growth factor-A (VEGF-A) and stage/size of the hydrocele. Wolbachia sp. loads/microfilaria, microfilaremia, and antigenemia were significantly reduced in the doxycycline-treated patients compared with the placebo group. The mean plasma levels of VEGF-A were decreased significantly in the doxycycline-treated patients who had active infection. This finding preceded the reduction of the stage of hydrocele. A six-week regimen of doxycycline treatment against filariasis showed amelioration of pathologic conditions of hydrocele patients with active infection.


Asunto(s)
Antibacterianos/uso terapéutico , Doxiciclina/uso terapéutico , Hidrocele Testicular/tratamiento farmacológico , Factor A de Crecimiento Endotelial Vascular/sangre , Wolbachia/efectos de los fármacos , Wuchereria bancrofti/microbiología , Adolescente , Adulto , Albendazol/uso terapéutico , Animales , Antibacterianos/farmacología , Método Doble Ciego , Doxiciclina/farmacología , Filariasis/complicaciones , Filariasis/tratamiento farmacológico , Filaricidas/uso terapéutico , Ghana/epidemiología , Humanos , Ivermectina/uso terapéutico , Masculino , Persona de Mediana Edad , Hidrocele Testicular/sangre , Hidrocele Testicular/epidemiología , Hidrocele Testicular/etiología , Adulto Joven
4.
J Trop Med Hyg ; 96(5): 317-22, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8411308

RESUMEN

A filariasis prevalence survey was conducted in April 1992 in the Southern sector of the Kassena Nankana District which was the site of the Ghana Vitamin A Supplementation morbidity trial. In all, 106 compounds from five different communities were randomly selected from the vitamin A trial database. All resident compound members of 10 years and above were clinically examined and blood was taken for thick films between 2100 and 0200 hours. Haemoglobin levels were also measured. All the blood slides were examined by the investigators in Navrongo. Two reference laboratories examined 10% each of the slides for quality control. In all, 531 people were examined, 247 males and 284 females. The results showed an overall microfilaraemia rate of 41.1% (95% CI 36.9-45.3%). The only species identified was Wuchereria bancrofti. The most important clinical manifestation was hydrocele, 30.8% of males (95% CI 25-36.6%); followed by elephantiasis of the leg, 3.6% of the study population (95% CI 2.0-5.2%). The mean haemoglobin level of the population was 12.4 g dl-1. There were no significant differences between the communities in clinical or parasitological findings.


Asunto(s)
Filariasis Linfática/epidemiología , Wuchereria bancrofti/aislamiento & purificación , Adolescente , Adulto , Factores de Edad , Animales , Niño , Filariasis Linfática/sangre , Filariasis Linfática/complicaciones , Femenino , Ghana/epidemiología , Hemoglobinas/análisis , Humanos , Ganglios Linfáticos/patología , Masculino , Microfilarias/aislamiento & purificación , Persona de Mediana Edad , Morbilidad , Prevalencia , Factores de Riesgo , Hidrocele Testicular/epidemiología , Hidrocele Testicular/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA